Mechanical Control of Cell Proliferation Increases Resistance to Chemotherapeutic Agents.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Rizzuti, Ilaria FrancescaMascheroni, Pietro
Arcucci, Silvia
Ben-Mériem, Zacchari
Prunet, Audrey
Barentin, Catherine
Rivière, Charlotte
Delanoë-Ayari, Hélène
Hatzikirou, Haralampos
Guillermet-Guibert, Julie
Delarue, Morgan
Issue Date
2020-09-18
Metadata
Show full item recordAbstract
While many cellular mechanisms leading to chemotherapeutic resistance have been identified, there is an increasing realization that tumor-stroma interactions also play an important role. In particular, mechanical alterations are inherent to solid cancer progression and profoundly impact cell physiology. Here, we explore the influence of compressive stress on the efficacy of chemotherapeutics in pancreatic cancer spheroids. We find that increased compressive stress leads to decreased drug efficacy. Theoretical modeling and experiments suggest that mechanical stress decreases cell proliferation which in turn reduces the efficacy of chemotherapeutics that target proliferating cells. Our work highlights a mechanical form of drug resistance and suggests new strategies for therapy.Citation
Phys Rev Lett. 2020 Sep 18;125(12):128103. doi: 10.1103/PhysRevLett.125.128103.Affiliation
BRICS, Braunschweiger Zentrum für Systembiologie, Rebenring 56,38106 Braunschweig, Germany.Publisher
American Physical SocietyJournal
Physical review lettersPubMed ID
33016731Type
ArticleLanguage
enEISSN
1079-7114ae974a485f413a2113503eed53cd6c53
10.1103/PhysRevLett.125.128103
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
Related articles
- Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer.
- Authors: Dufau I, Frongia C, Sicard F, Dedieu L, Cordelier P, Ausseil F, Ducommun B, Valette A
- Issue date: 2012 Jan 13
- Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype.
- Authors: Hu G, Li F, Ouyang K, Xie F, Tang X, Wang K, Han S, Jiang Z, Zhu M, Wen D, Qin X, Zhang L
- Issue date: 2012 Mar
- Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer.
- Authors: Venkatasubbarao K, Peterson L, Zhao S, Hill P, Cao L, Zhou Q, Nawrocki ST, Freeman JW
- Issue date: 2013 Sep 11
- Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient-derived xenograft tumors.
- Authors: Dhar D, Raina K, Kumar D, Wempe MF, Bagby SM, Pitts TM, Orlicky DJ, Agarwal C, Messersmith WA, Agarwal R
- Issue date: 2020 Oct
- A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics.
- Authors: Ocal O, Pashkov V, Kollipara RK, Zolghadri Y, Cruz VH, Hale MA, Heath BR, Artyukhin AB, Christie AL, Tsoulfas P, Lorens JB, Swift GH, Brekken RA, Wilkie TM
- Issue date: 2015 Oct 1